Histological patterns and associated PSA levels for prostatic adenocarcinoma following brachytherapy-Reference-Cited by-同舟云学术

Histological patterns and associated PSA levels for prostatic adenocarcinoma following brachytherapy

Published:2009-12 Issue:12 Volume:205 Page:843-846
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Xiao Guang-Qian,Huan Youming,Stone Nelson,Stock Richard,Unger Pamela D.

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference22 articles.

1. Guidelines for PSA following radiation therapy;Int. J. Radiat. Oncol. Biol. Phys.,1997

2. Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer;Cavanagh;Semin. Urol. Oncol.,2000

3. Diagnosis of prostate cancer in needle biopsies after radiation therapy;Cheng;Am. J. Surg. Pathol.,1999

4. Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure;Crook;Urology,1998

5. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients;Crook;Int. J. Radiat. Oncol. Biol. Phys.,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with PSA below 0.2 ng/mL at 8 years post high‐dose‐rate brachytherapy have an extremely low risk of subsequent recurrence;International Journal of Urology;2023-08-31

2. Factors associated with late local failure and its influence on survival in men undergoing prostate brachytherapy;Brachytherapy;2022-07

3. How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?;International Journal of Clinical Oncology;2021-10-02

4. Patterns of Local Failure following Radiation Therapy for Prostate Cancer;Journal of Urology;2015-10

5. The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer;Brachytherapy;2015-05